Literature DB >> 7664836

Telomere shortening is associated with cell division in vitro and in vivo.

R C Allsopp1, E Chang, M Kashefi-Aazam, E I Rogaev, M A Piatyszek, J W Shay, C B Harley.   

Abstract

In humans, the amount of terminal (TTAGGG)n, telomeric DNA decreases during aging of various somatic cell types in vitro and in vivo. While the factors accounting for telomere shortening have not been thoroughly established, the inability of the DNA replication machinery to completely copy chromosomal termini (the "end replication problem") and the absence in somatic cells of telomerase, the enzyme that synthesizes telomeric DNA de novo, is a likely mechanism. One prediction of this hypothesis is that telomere shortening should be dependent on cell division. Thus we analyzed telomere length in actively dividing and quiescent cells in vitro and in vivo. In circular outgrowths of cultured human diploid fibroblasts (HDF), cells at the outer periphery had a significantly lower mean terminal restriction fragment (TRF) length (P = 0.011) and telomeric signal intensity (P = 0.024) than cells at the center. Also, the rate of telomere shortening over time for HDFs held quiescent was not statistically significant (m = -12 bp/day, P = 0.16) while that for serially passaged cells was significant (m = -34 bp/day, P = 0.017). To examine the rate of telomere shortening for quiescent cells in vivo, we measured mean TRF length in brain tissue from adult donors ranging in age from 32-75 years. No significant decrease was observed as a function of donor age (P = 0.087), in contrast to the shortening of telomere length that occurs during in vivo aging of mitotically active cells (P = 0.0001). These observations show that telomere shortening is largely, if not entirely, dependent on cell division and support the end replication problem as a mechanism for this process and the use of telomere length as a biomarker for replicative capacity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7664836     DOI: 10.1006/excr.1995.1306

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  111 in total

Review 1.  Natural and pharmacological regulation of telomerase.

Authors:  Jean-Louis Mergny; Jean-François Riou; Patrick Mailliet; Marie-Paule Teulade-Fichou; Eric Gilson
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

2.  Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining.

Authors:  Alan K Meeker; Wesley R Gage; Jessica L Hicks; Inpakala Simon; Jonathan R Coffman; Elizabeth A Platz; Gerrun E March; Angelo M De Marzo
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

3.  Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues.

Authors:  R P Bucy; R D Hockett; C A Derdeyn; M S Saag; K Squires; M Sillers; R T Mitsuyasu; J M Kilby
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

4.  Telomerase expression in uveal melanoma.

Authors:  B Heine; S E Coupland; S Kneiff; G Demel; N Bornfeld; M Hummel; H Stein
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

Review 5.  The peripheral generation of CD4+ CD25+ regulatory T cells.

Authors:  Arne N Akbar; Leonie S Taams; Mike Salmon; Milica Vukmanovic-Stejic
Journal:  Immunology       Date:  2003-07       Impact factor: 7.397

6.  Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells.

Authors:  A Satyanarayana; S U Wiemann; J Buer; J Lauber; K E J Dittmar; T Wüstefeld; M A Blasco; M P Manns; K L Rudolph
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

7.  Telomerase activity detected in oral lichen planus by RNA in situ hybridisation: not a marker for malignant transformation.

Authors:  C O'Flatharta; M Leader; E Kay; S R Flint; M Toner; W Robertson; M J E M F Mabruk
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

8.  Heterocyclic dications as a new class of telomeric G-quadruplex targeting agents.

Authors:  Rupesh Nanjunda; Caterina Musetti; Arvind Kumar; Mohamed A Ismail; Abdelbasset A Farahat; Siming Wang; Claudia Sissi; Manlio Palumbo; David W Boykin; W David Wilson
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 9.  Central nervous system myeloid cells as drug targets: current status and translational challenges.

Authors:  Knut Biber; Thomas Möller; Erik Boddeke; Marco Prinz
Journal:  Nat Rev Drug Discov       Date:  2015-12-04       Impact factor: 84.694

10.  Telomere length and replicative aging in human vascular tissues.

Authors:  E Chang; C B Harley
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.